Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases

Trenton R Schoeb1, Daniel C Bullard

  • 1Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0024, USA.

Insights

Researchers urge detailed reporting of microbial status and histopathology methods in mouse models for inflammatory bowel disease research. Clearer documentation ensures accurate interpretation of disease phenotypes and experimental outcomes.

Area of Science:

  • Microbiology
  • Immunology
  • Animal Models

Background:

  • Mouse models are crucial for studying inflammatory bowel disease (IBD).
  • Current reporting often lacks critical details on mouse microbial status and disease assessment methods.
  • This omission can hinder the reproducibility and interpretation of IBD research findings.

Purpose of the Study:

  • To highlight the necessity for precise reporting of microbial status in mouse models.
  • To emphasize the importance of detailed histopathological assessment methods in IBD research.
  • To advocate for improved standards in documenting mouse models for enhanced scientific rigor.

Main Methods:

  • Review of common practices in reporting mouse model studies for IBD.
  • Identification of critical information gaps in current scientific literature.
  • Formulation of recommendations for authors regarding microbial status and histopathology reporting.

Main Results:

  • Many mouse model studies fail to specify the microbial agents (e.g., Helicobacter spp.) from which mice are considered free.
  • Histopathology methods for evaluating colitis are frequently described inadequately.
  • Photomicrographs used for lesion assessment are often too small or of insufficient resolution.

Conclusions:

  • Precise terminology (e.g., "conventional," "specific pathogen-free") and health monitoring details are essential.
  • Comprehensive descriptions of histopathology techniques and high-quality images are necessary for valid interpretation.
  • Improved reporting standards will enhance the reliability and reproducibility of mouse model-based IBD research.